Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3/4 Chronic Kidney Disease (CKD) With Secondary Hyperparathyroidism (SHPT)

NCT00823303 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

110

Enrollment

OTHER

Sponsor class

Conditions

Secondary Hyperparathyroidism
Chronic Kidney Disease

Interventions

DRUG: Paricalcitol
DRUG: Calcitriol

Sponsor

Washington University School of Medicine

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]